Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 35NIH 6NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other neoplasm 1Gynecologic 1Breast 1

Conditions

Rectal Neoplasms 1Pain 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Body Weight Changes 1Anxiety Disorders 1

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Counseling × Breast × Clear all
NCT01453452 2020-01-18

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

SWOG Cancer Research Network

Phase NA Completed
50 enrolled
BreastGastrointestinal

Anxiety Disorders, Body Weight Changes, Breast Neoplasms, Colonic Neoplasms, Depression, Fatigue, Pain, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡